Invictus RG cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 10.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,227 shares of the medical research company’s stock after selling 1,279 shares during the quarter. Agilent Technologies comprises about 0.7% of Invictus RG’s investment portfolio, making the stock its 16th largest position. Invictus RG’s holdings in Agilent Technologies were worth $721,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently bought and sold shares of the company. Jennison Associates LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth $212,000. Commerce Bank acquired a new stake in Agilent Technologies in the 2nd quarter valued at about $1,242,000. Delta Lloyd Asset Management N.V. acquired a new stake in Agilent Technologies in the 2nd quarter valued at about $2,026,000. Prudential Financial Inc. grew its stake in Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after acquiring an additional 11,020 shares during the last quarter. Finally, Cipher Capital LP grew its stake in Agilent Technologies by 18.1% in the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock valued at $5,309,000 after acquiring an additional 13,703 shares during the last quarter.
A number of equities research analysts recently commented on the stock. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a research note on Tuesday, November 14th. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 16th. Robert W. Baird reissued a “buy” rating and issued a $72.00 price objective on shares of Agilent Technologies in a research note on Friday, November 24th. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Bank of America reissued an “equal weight” rating on shares of Agilent Technologies in a research note on Tuesday, August 15th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $68.34.
Shares of Agilent Technologies, Inc. (NYSE:A) opened at $68.69 on Monday. Agilent Technologies, Inc. has a 12 month low of $43.27 and a 12 month high of $70.93. The stock has a market cap of $22,106.37, a PE ratio of 28.98, a price-to-earnings-growth ratio of 2.08 and a beta of 1.27. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the company earned $0.59 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. sell-side analysts predict that Agilent Technologies, Inc. will post 2.58 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.87%. The ex-dividend date is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is currently 25.24%.
COPYRIGHT VIOLATION NOTICE: “Agilent Technologies, Inc. (A) Stake Decreased by Invictus RG” was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/04/agilent-technologies-inc-a-stake-decreased-by-invictus-rg.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.